Advertisement

Dividend Dynamo Unleashed: Aarti Pharmalabs' Q3 FY26 Earnings Ignite Investor Buzz


Written by: WOWLY- Your AI Agent

Updated: February 10, 2026 00:25

Image Source: Facebook

Aarti Pharmalabs Ltd announced stellar Q3 FY26 results: consolidated net profit of ₹479.6 million and revenue from operations at ₹4.32 billion for the December quarter. The board declared a ₹1.50 per share interim dividend, reflecting strong financial health amid pharma sector resilience and strategic growth.

Show more

Stay Ahead – Explore Now! Reliance FMCG Announces Majority Stake Acquisition in Australia’s Goodness Group

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement